Literature DB >> 15923520

Vitreous amyloidosis in alanine 71 transthyretin mutation.

H J Zambarakji, D G Charteris, W Ayliffe, P J Luthert, F Schon, P N Hawkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923520      PMCID: PMC1772703          DOI: 10.1136/bjo.2004.057554

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Familial primary amyloidosis with nervous system involvement.

Authors:  A D KANTARJIAN; R N DEJONG
Journal:  Neurology       Date:  1953-06       Impact factor: 9.910

2.  Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up.

Authors:  E Ando; Y Ando; R Okamura; M Uchino; M Ando; A Negi
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

3.  Transthyretin ALA 71: a new transthyretin variant in a Spanish family with familial amyloidotic polyneuropathy.

Authors:  M do R Almeida; F Lopez-Andreu; M Munar-Qués; P P Costa; M J Saraiva
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

4.  Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.

Authors:  M Munar-Qués; L Salva-Ladaria; P Mulet-Perera; M Solé; F R López-Andreu; M J Saraiva
Journal:  Amyloid       Date:  2000-12       Impact factor: 7.141

5.  The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye.

Authors:  T Cavallaro; R L Martone; A J Dwork; E A Schon; J Herbert
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-03-01       Impact factor: 4.799

6.  Tabulation of transthyretin (TTR) variants as of 1/1/2000.

Authors:  L H Connors; A M Richardson; R Théberge; C E Costello
Journal:  Amyloid       Date:  2000-03       Impact factor: 7.141

7.  A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.

Authors:  M D Benson; J C Turpin; G Lucotte; S Zeldenrust; B LeChevalier; M D Benson
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

8.  Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.

Authors:  Takahisa Koga; Eiko Ando; Akira Hirata; Mikiko Fukushima; Akira Kimura; Yukio Ando; Akira Negi; Hidenobu Tanihara
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

9.  Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.

Authors:  A Rydh; O Suhr; S O Hietala; K R Ahlström; M B Pepys; P N Hawkins
Journal:  Eur J Nucl Med       Date:  1998-07
  9 in total
  3 in total

1.  Vitrectomy for vitreous amyloidosis.

Authors:  Jiang You
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

2.  Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.

Authors:  T Liu; B Zhang; X Jin; W Wang; J Lee; J Li; H Yuan; X Cheng
Journal:  Eye (Lond)       Date:  2013-10-11       Impact factor: 3.775

3.  Transthyretin Arg-83 mutation in vitreous amyloidosis.

Authors:  Ling-Yan Chen; Lin Lu; Yong-Hao Li; Hui Zhong; Wang Fang; Li Zhang; Weng-Lin Li
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.